Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia
Objective. To develop criteria for determining the duration of anti-inflammatory therapy and indications for withdrawal of inhaled corticosteroids (ICS) in children with bronchopulmonary dysplasia (BPD). Materials and methods. A total of 56 premature infants with moderate to severe (group 1) and...
Saved in:
| Main Authors: | Т. І. Stepanenko, I. M. Khrystosova, H. V. Rukavytsia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2019-04-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/161494/162161 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced vs. standard low dose dexamethasone treatment on respiratory outcomes of preterm infants with bronchopulmonary dysplasia
by: Sezgin Gunes, et al.
Published: (2025-08-01) -
A Comparison of the 2022 Versus 2011 National Institute of Child Health and Human Development Web-Based Risk Estimator for Bronchopulmonary Dysplasia
by: Mitchell Kinkor, MD, et al.
Published: (2024-12-01) -
Efficacy of vibroacoustic therapy in treatment of pneumonia in children with bronchopulmonary dysplasia
by: Madina Syzdykova, et al.
Published: (2023-09-01) -
Correlates of Elevated Interleukin-6 and 8-Hydroxy-2′-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia
by: Chien-Chou Hsiao, et al.
Published: (2017-02-01) -
A Practical, Evidence-Based Approach to Postneonatal Management of Children with Bronchopulmonary Dysplasia
by: Caroline Poulter, et al.
Published: (2019-07-01)